Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
Compounders ordered to halt production of semaglutide knockoffs
A U.S. court dismissed a bid by compounding pharmacies to continue to produce copycats of Novo Nordisk’s semaglutide while a lawsuit plays out.
Kevin Dunleavy
Apr 25, 2025 10:25am
Compounder in Lilly lawsuit hit with FDA warning letter
Apr 24, 2025 8:20am
Novo Nordisk applies for FDA approval of semaglutide obesity pill
Apr 22, 2025 8:50am
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 3:00am
BMO says Lilly is pulling ahead of Novo in obesity market battle
Apr 17, 2025 4:30pm
Pharmas demand changes to stay in EU amid looming Trump tariffs
Apr 16, 2025 10:41am
